Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal
NCT06152055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76
Last updated 2023-11-30
Summary
This is a observational study conducted at the department of Ear ,Nose and Throat -Head and Neck Surgery (ENT-HNS) of Shree Birendra Hospital ,a tertiary health care centre of Nepal. Head and Neck cancers are the sixth most common cancer in the world. Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023.The main aim of the study was to know about the common cancers of head and neck region and their distribution according to the site. Also to know the stage of the presentation with treatment modalities in the tertiary health care centre of Nepal.
Conditions
Sponsors & Collaborators
-
Tribhuvan University, Nepal
lead OTHER
Principal Investigators
-
Reeba Karki, MS · Shree Birendra Hospital
Eligibility
- Min Age
- 17 Years
- Max Age
- 84 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-01
- Primary Completion
- 2023-04-30
- Completion
- 2023-04-30
Countries
- Nepal
Study Locations
More Related Trials
-
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT06136962 ·Status: NOT_YET_RECRUITING
-
Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00652613 ·Status: UNKNOWN ·Phase: PHASE2
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread
NCT03569436 ·Status: COMPLETED
-
Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT
NCT04996147 ·Status: TERMINATED
-
Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00623558 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma
NCT06465030 ·Status: RECRUITING
-
The Clinical Relevance of Immune Cells and CTC in HNSCC Patients
NCT02420600 ·Status: UNKNOWN
-
Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
NCT03114163 ·Status: COMPLETED
-
H&N Cancer; Survivorship and Late Effects
NCT04758026 ·Status: COMPLETED
-
Head and Neck Cancer in Children: A Retrospective Study
NCT02557048 ·Status: UNKNOWN
-
Real-World Evidence and Treatment Patterns: Head and Neck Cancer
NCT03157674 ·Status: COMPLETED
-
Head and Neck Early Relapse Detection Study (HERD)
NCT05097625 ·Status: RECRUITING
-
Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer
NCT06360978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Re-irradiation of Recurrent Head and Neck Cancer
NCT01973179 ·Status: ACTIVE_NOT_RECRUITING
-
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT03370276 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833 ·Status: COMPLETED
-
WGA in Platinum-refractory HNSCC Underwent Nivolumab
NCT03917537 ·Status: UNKNOWN
-
AIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944 ·Status: RECRUITING
-
Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma (neoHNSCC)
NCT06011993 ·Status: UNKNOWN
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097 ·Status: COMPLETED
-
Adverse Events for Free Flap Surgery in Head and Neck Cancer
NCT06371365 ·Status: COMPLETED
-
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT06100497 ·Status: RECRUITING ·Phase: PHASE2
-
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
NCT06170697 ·Status: UNKNOWN ·Phase: PHASE2
-
The Impact of Multimodality Treatment on Physical Functions and Quality of Life in Patients With Head and Neck Cancer
NCT05036902 ·Status: COMPLETED